GlassScriptPhysician profile
Kun Woo Nam
NPI 1851409189
$1,198.49
in general payments reported to CMS, 2019-2025
23 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $579 · 2020: $604 · 2022: $14.95.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $304.65 | 2019-2020 | |
| Amarin Pharma, INC. | $160.01 | 2019-2020 | |
| Janssen Pharmaceuticals, INC | $129.98 | 2019-2020 | |
| Astrazeneca Pharmaceuticals LP | $87.57 | 2019-2020 | |
| Lilly USA, LLC | $81.92 | 2019-2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $81.69 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $37.88 | 2019-2020 | |
| Amgen INC. | $30.24 | 2019 | |
| Abbvie INC. | $28.63 | 2019-2020 | |
| Novo Nordisk INC | $27.60 | 2019 | |
| Pfizer INC. | $27.06 | 2019-2020 | |
| Novartis Pharmaceuticals Corporation | $25.71 | 2019 | |
| Glaxosmithkline, LLC. | $20.15 | 2019 | |
| Teva Pharmaceuticals USA, INC. | $19.88 | 2019 | |
| Arbor Pharmaceuticals, INC. | $17.82 | 2020 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ironwood Pharmaceuticals, INC | $17.77 | 2020 | |
| Vanda Pharmaceuticals INC. | $17.35 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $15.23 | 2020 | |
| Astellas Pharma US INC | $14.92 | 2019 | |
| Daiichi Sankyo INC. | $13.67 | 2020 | |
| Jazz Pharmaceuticals INC. | $13.08 | 2020 | |
| E.R. Squibb & Sons, L.L.C. | $12.98 | 2020 | |
| Kowa Pharmaceuticals America, INC. | $12.70 | 2020 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kun Nam listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.